Antibiotic therapy for pelvic inflammatory disease.
CONCLUSIONS: We are uncertain whether one treatment was safer or more effective than any other for the cure of mild-moderate or severe PID Based on a single study at a low risk of bias, a macrolide (azithromycin) probably improves the rates of cure of mild-moderate PID, compared to tetracycline (doxycycline).
PMID: 32820536 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Savaris RF, Fuhrich DG, Maissiat J, Duarte RV, Ross J Tags: Cochrane Database Syst Rev Source Type: research
More News: Antibiotic Therapy | Azithromycin | Clindamycin | Databases & Libraries | Doxycycline | General Medicine | Laparoscopy | Metronidazole | Reproduction Medicine | STDs | Study | Tetracycline | Women | Zithromax